- Home
- HTHT vs ASND Comparison
HTHT vs ASND Comparison
Compare HTHT & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HTHT | ASND |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | China | Denmark |
| Employees | 26458 | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5B | 15.0B |
| IPO Year | 2010 | 2014 |
Fundamental Metrics
Financial Performance| Metric | HTHT | ASND |
|---|---|---|
| Price | $46.50 | $225.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 21 |
| Target Price | $61.52 | ★ $306.03 |
| AVG Volume (30 Days) | ★ 1.0M | 757.5K |
| Earning Date | 11-16-2026 | 11-11-2026 |
| Dividend Yield | ★ 4.59% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.22 | $90.81 |
| Revenue Next Year | $6.10 | $46.89 |
| P/E Ratio | $30.34 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $37.60 | $186.05 |
| 52 Week High | $56.53 | $282.15 |
Technical Indicators
Market Signals| Indicator | HTHT | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 67.35 | 41.29 |
| Support Level | $42.12 | $216.52 |
| Resistance Level | $50.42 | $249.89 |
| Average True Range (ATR) | 0.93 | 5.64 |
| MACD | 0.50 | 0.75 |
| Stochastic Oscillator | 97.18 | 41.75 |
Price Performance
Historical ComparisonAbout HTHT H World Group Limited
H World Group Ltd a foremost, fast-growing multi-brand hotel group with international operations. The principal business activities of the Company are to develop and operate leased and owned, manachised and franchised hotels mainly in the PRC or PRC Mainland. The Group has two operating segments which are legacy Huazhu and legacy DH according to the way management intends to evaluate results and allocate resources within the Group. The majority of revenue comes from legacy Huazhu. The company has presence in Greater China and also Outside Greater China.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.